Evidence map›Paper›PMID 39751981›Full record

ArticleAnnals of surgical oncology2025

Defining Textbook Outcomes for Minimally Invasive Surgical Resection of Small Gastrointestinal Stromal Tumors (GIST) of the Stomach.

Graham J Spurzem, Priyanka S Jadhav, Taylor Nordan, Chandrajit P Raut, Santiago Horgan, Jiping Wang, Jason K Sicklick

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Graham J SpurzemDepartment of Surgery, Division of Minimally Invasive Surgery, University of California San Diego, San Diego, CA, USA.
Priyanka S JadhavDepartment of Surgery, University of California San Diego School of Medicine, San Diego, CA, USA.
Taylor NordanDepartment of Surgery, Division of Surgical Oncology, Brigham and Women's Hospital, Boston, MA, USA.
Chandrajit P RautDepartment of Surgery, Division of Surgical Oncology, Brigham and Women's Hospital, Boston, MA, USA.
Santiago HorganDepartment of Surgery, Division of Minimally Invasive Surgery, University of California San Diego, San Diego, CA, USA.
Jiping WangDepartment of Surgery, Division of Surgical Oncology, Brigham and Women's Hospital, Boston, MA, USA.
Jason K SicklickDepartment of Surgery, University of California San Diego School of Medicine, San Diego, CA, USA. jsicklick@health.ucsd.edu.

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jesse Nodora · 1985 to 2026
$124.9M
Targeting Drug-Resistant Cancer Stem Cell Niches of Gastrointestinal Stromal TumorR01CA226803 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SICKLICK, JASON KEITH · 2019 to 2023
$2.1M
National Succinate Dehydrogenase-deficient GIST Translational Research and Clinical Trial ConsortiumU01CA278470 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JOHN Walter GLOD, Jason Keith Sicklick · 2024 to 2026
$1.8M
FDA HHS R01 FD006334NCI NIH HHS P30 CA023100NCI NIH HHS R01 CA226803NCI NIH HHS U01 CA278470
6 · The paper itself

Abstract

backgroundTextbook outcome (TO) has been utilized to assess the quality of surgical care. This study aimed to define TO rates for minimally invasive gastric gastrointestinal stromal tumor (GIST) resections in a bi-institutional cohort.

methodsPatients with gastric GIST (≤ 5 cm) who underwent laparoscopic or robotic resection (January 2014 to January 2024) were retrospectively identified from two GIST centers. We excluded patients with concurrent procedures, tumor involvement of adjacent organs, or metastatic disease. To balance perioperative and oncologic outcomes, we defined TO as: R0 resection, no conversion to open surgery, operative time ≤ 120 min, no perioperative transfusions, no intraoperative complications, no Clavien-Dindo ≥ II complications, hospital length of stay (LOS) ≤ 3 days, no 90-day readmission or death, no tumor rupture, and recurrence-free status at 2 years (5% predicted recurrence risk for tumors with a low mitotic index).

resultsA total of 83 patients were included. TO was achieved in 62.7% of cases (N = 52). Mean tumor size was 3.0 ± 1.0 cm and 86.7% of GIST were modified-NIH low or very low risk (i.e., mitotic index ≤5/mm

conclusionsMinimally invasive gastric GIST resection is well-described. Herein, we propose new TO standards to serve as a measure of short- and long-term outcomes for monitoring institutional performance.

Indexed as

GastrectomyGastrointestinal Stromal TumorsLaparoscopyMinimally Invasive Surgical ProceduresNeoplasm Recurrence, LocalPostoperative ComplicationsRobotic Surgical ProceduresStomach NeoplasmsAdultAgedFemaleFollow-Up StudiesHumansLength of StayMaleMiddle AgedGastrointestinal stromal tumorLaparoscopyMinimally invasive surgeryRobotic surgeryStomachTextbook outcome

Identifiers

PMID39751981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.